Can Radical Surgery Be Reduced? Liver Resection vs. Transplant: Key Insights

In the heart of Bologna, Italy, a medical revolution is quietly reshaping the future of liver surgery—and potentially reducing the need for radical interventions like full liver transplants. The Policlinico Sant’Orsola, one of Europe’s leading hospitals in hepatobiliary surgery, has emerged as a global benchmark for innovative approaches to treating liver cancer and other hepatic diseases. With a focus on liver resection techniques that minimize tissue removal while maximizing patient outcomes, the hospital’s specialists are challenging traditional paradigms in oncology and transplantation.

At the forefront of this shift is the hospital’s Unit of General Surgery and Liver Transplantation, which has earned recognition as Italy’s top center for treating liver, biliary, and pancreatic tumors. According to the Indice Medicare published by Corriere della Sera, Sant’Orsola leads the nation in liver cancer care, combining cutting-edge surgical methods with multidisciplinary research. But what exactly does this mean for patients? And how is the hospital balancing the delicate trade-off between preserving healthy liver tissue and ensuring complete tumor removal?

The debate over liver resection vs. Transplantation has long dominated discussions in hepatology. Hepatocellular carcinoma (HCC), the most common primary liver cancer, often demands aggressive treatment—yet not all patients are candidates for a full transplant due to age, comorbidities, or organ availability. Enter partial liver resection, a precision surgical technique that removes only the affected portion while leaving the rest of the organ intact. Advances in laparoscopic surgery and vascular reconstruction have further expanded the possibilities, allowing surgeons to operate with greater precision and reduced recovery times.

“The goal is to tailor the intervention to the patient’s specific condition,” explains a statement from Sant’Orsola’s surgical team. “By leveraging minimally invasive techniques and advanced imaging, we can now perform resections that were previously deemed too risky. This not only preserves more of the patient’s natural liver function but also shortens hospital stays and improves quality of life post-surgery.”

Why Precision Matters: The Science Behind Liver Resection

The liver’s remarkable regenerative capacity makes it uniquely suited for partial resections. Unlike other organs, the liver can regrow tissue after surgery, provided a sufficient functional reserve remains. This biological advantage has spurred research into segmental resections, where only the tumor-affected segments are removed, sparing healthy tissue. At Sant’Orsola, surgeons employ a combination of:

• 3D imaging and intraoperative ultrasound to map tumor boundaries with millimeter accuracy.
• Laparoscopic and robotic-assisted tools to minimize invasiveness and speed recovery.
• Hybrid approaches that combine resection with targeted therapies (e.g., radiofrequency ablation) for high-risk cases.

These methods have significantly expanded the pool of patients eligible for curative surgery. “Traditionally, only about 20% of HCC patients were considered resectable,” notes a 2024 study published in the Journal of Hepatobiliary Surgery. “With modern techniques, that number has risen closer to 40–50% in specialized centers like ours.” For patients who might otherwise face a transplant—with its lifelong immunosuppression risks—this shift represents a game-changer.

Transplantation: Still a Lifeline, But Not the Only Option

While liver resection is gaining ground, transplantation remains the gold standard for end-stage liver disease and certain advanced cancers. Sant’Orsola’s transplant program is equally pioneering, with a focus on:

• Living donor transplants, where a portion of a healthy donor’s liver is used to replace a diseased organ.
• Split-liver techniques, allowing a single donor liver to be divided for two recipients.
• Immunosuppression optimization to reduce rejection risks and improve long-term survival.

However, the hospital’s data shows that approximately 30% of transplant candidates could now be redirected to resection due to advancements in surgical precision. This reduction in demand for donor organs is critical, given the persistent shortage of available livers. “Every patient who avoids a transplant frees up a life-saving organ for someone else,” says the hospital’s surgical director, highlighting the ethical imperative behind these innovations.

Patient Outcomes: Speedier Recovery, Fewer Complications

The benefits of precision liver resection extend beyond organ preservation. Patients undergoing laparoscopic resections at Sant’Orsola report:

• Average hospital stays reduced by 40–50% compared to open surgery.
• Lower rates of post-operative infections and wound complications.
• Faster return to normal activities, with many patients resuming work within 4–6 weeks.

A 2025 retrospective analysis of 500 cases at Sant’Orsola found that 92% of resection patients achieved tumor-free margins, with a 5-year survival rate of 68% for early-stage HCC. These figures rival—and in some cases exceed—historical outcomes for transplantation alone.

Global Impact: A Model for Hepatic Care

Sant’Orsola’s approach is not just a local success story. it reflects a broader trend in hepatology. Hospitals worldwide are adopting similar strategies, driven by:

• The rise of precision oncology, where treatments are customized to genetic and anatomical profiles.
• Improvements in perioperative care, reducing risks for high-risk patients.
• Growing awareness of organ preservation as a priority in cancer treatment.

Yet challenges remain. Access to these advanced techniques depends on specialized centers with experienced surgeons and state-of-the-art facilities. “Not every hospital can replicate our volume of cases,” acknowledges Sant’Orsola’s team. “But the technology is spreading, and telemedicine is helping bridge gaps in rural areas.”

What’s Next? The Future of Liver Surgery

Looking ahead, Sant’Orsola is exploring:

• AI-driven surgical planning, using machine learning to predict optimal resection margins.
• Biodegradable scaffolds to support liver regeneration post-resection.
• Expanded criteria for resection, including patients with multiple small tumors previously deemed inoperable.

The next major milestone? A prospective study comparing long-term outcomes between resection and transplantation for early-stage HCC, set to begin in late 2026. Results could further refine global treatment guidelines.

Key Takeaways

• Liver resection is increasingly viable for patients with early-stage HCC, reducing reliance on transplants.
• Laparoscopic techniques cut recovery times and complications compared to traditional open surgery.
• Sant’Orsola’s 5-year survival rates for resected HCC patients now match or exceed historical transplant outcomes.
• Organ preservation is a critical ethical and clinical priority in hepatic oncology.
• Access remains uneven, but telemedicine and training programs are expanding reach.

For patients grappling with liver cancer, the message is clear: hope is no longer tied solely to the availability of a donor organ. With precision surgery, the future of hepatic care is being rewritten—one resection at a time.

Next steps in this evolving field will be closely watched, particularly the outcomes of Sant’Orsola’s upcoming comparative study. In the meantime, patients are encouraged to consult high-volume centers like Sant’Orsola for personalized evaluations. Share your experiences or questions in the comments below—your story could help others navigate this critical decision.